These in vivo results are highly in agreement with the in vitro data, thereby demonstrating that the cGAS‐STING pathway is crucial for OMVs‐ and IR700‐modified OMV‐mediated tumour suppression, potentially via activation of the systemic antitumour immunity. The gene discussed is STING1; the disease is neoplasm.